ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor

Xu, Wenjing; Cui, Changting; Cui, Chunmei; Chen, Zhenzhen; Zhang, Haizeng; Cui, Qinghua; Xu, Guoheng; Fan, Jianglin; Han, Yu; Tang, Liangjie; Targher, Giovanni; Byrne, Christopher D.; Zheng, Ming-Hua*; Yang, Liming*; Cai, Jun*; Geng, Bin*北京大学; 哈尔滨医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
Hepatology2022-12DOI: 10.1002/hep.32577
19被引7阅读
引用收藏
分享

摘要

Background and Aims Hydrogen sulfide (H2S) plays a protective role in NAFLD. However, whether cystathionine gamma lyase (CSE), a dominant H2S generating enzyme in hepatocytes, has a role in the pathogenesis of NAFLD is currently unclear. Approach and Results We showed that CSE protein expression is dramatically downregulated, especially in fibrotic areas, in livers from patients with NAFLD. In high-fat diet (HFD)-induced NAFLD mice or an oleic acid-induced hepatocyte model, the CSE/H2S pathway is also downregulated. To illustrate a regulatory role for CSE in NAFLD, we generated a hepatocyte-specific CSE knockout mouse (CSELKO). Feeding an HFD to CSELKO mice, they showed more hepatic lipid deposition with increased activity of the fatty acid de novo synthesis pathway, increased hepatic insulin resistance, and higher hepatic gluconeogenic ability compared to CSELoxp control mice. By contrast, H2S donor treatment attenuated these phenotypes. Furthermore, the protection conferred by H2S was blocked by farnesoid X receptor (FXR) knockdown. Consistently, serum deoxycholic acid and lithocholic acid (FXR antagonists) were increased, and tauro-beta-muricholic acid (FXR activation elevated) was reduced in CSELKO. CSE/H2S promoted a post-translation modification (sulfhydration) of FXR at Cys138/141 sites, thereby enhancing its activity to modulate expression of target genes related to lipid and glucose metabolism, inflammation, and fibrosis. Sulfhydration proteomics in patients' livers supported the CSE/H2S modulation noted in the CSELKO mice. Conclusions FXR sulfhydration is a post-translational modification affected by hepatic endogenous CSE/H2S that may promote FXR activity and attenuate NAFLD. Hepatic CSE deficiency promotes development of nonalcoholic steatohepatitis. The interaction between H2S and FXR may be amenable to therapeutic drug treatment in NAFLD.

学科与关键词

关键词
HYDROGEN-SULFIDEBILE-ACIDSOBETICHOLIC ACIDBETA-SYNTHASEFXRLYASESTEATOHEPATITISTRIGLYCERIDEEXPRESSIONGENE
相关
加载中…
  • Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
    Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*ACS OMEGA, 2023, 8(29): 26158-26169.
  • Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling
    Pan, Linyu; Yu, Ze; Liang, Xiaolin; Yao, Jiyou; Fu, Yanfang; He, Xu; Ren, Xiaoling; Chen, Jiajia; Li, Xuejuan; Lu, Minqiang*; Lan, Tian*Hepatology Communications, 2023, 7(2): e0039.
  • Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
    Kuang, Junliang; Wang, Jieyi; Li, Yitao; Li, Mengci; Zhao, Mingliang; Ge, Kun; Zheng, Dan; Cheung, Kenneth C. P.; Liao, Boya; Wang, Shouli; Chen, Tianlu; Zhang, Yinan; Wang, Congrong; Ji, Guang; Chen, Peng; Zhou, Hongwei; Xie, Cen; Zhao, Aihua; Jia, Weiping*; Zheng, Xiaojiao*; Jia, WeiCell Metabolism, 2023, 35(10): 1752-+.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology
发表日期
2022-12
卷期
第 76 卷, 第 6 期
页码
1794-1810
DOI
10.1002/hep.32577
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
CAMS Innovation Fund for Medical Sciences [2021-I2M-1-007]; High Level Creative Talents from Department of Public Health in Zhejiang Province [S2032102600032]; National Natural Science Foundation of China [81800367, 81825002, 81860111, 82000835, 81870318, 82100492]; Science Research Program of Xi'an Medical University [2020DOC13]

作者

  • X

    Xu, Wenjing (第一作者)

    xian med univ

  • C

    Cui, Changting

    chinese acad med sci · fuwai hosp · peking union med coll

查看全部 16 位作者收起作者
  • C

    Cui, Chunmei

    peking univ

  • C

    Chen, Zhenzhen

    chinese acad med sci · fuwai hosp · peking union med coll

  • Z

    Zhang, Haizeng

    chinese acad med sci · fuwai hosp · peking union med coll

  • C

    Cui, Qinghua

    peking univ

  • X

    Xu, Guoheng

    peking univ

  • F

    Fan, Jianglin

    xian med univ

  • H

    Han, Yu

    1 · wenzhou med univ

  • T

    Tang, Liangjie

    1 · wenzhou med univ

  • T

    Targher, Giovanni

  • B

    Byrne, Christopher D.

  • Z

    Zheng, Ming-Hua (通讯)

    1 · wenzhou med univ

  • Y

    Yang, Liming (通讯)

    harbin med univ

  • C

    Cai, Jun (通讯)

    chinese acad med sci · fuwai hosp · peking union med coll

  • G

    Geng, Bin (通讯)

    chinese acad med sci · fuwai hosp · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417